Gentra Systems Overview

  • Year Founded
  • 1988

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $38M

Gentra Systems General Information

Description

Provider of molecular-testing tools and sample-processing technologies designed for research, clinical, and applied laboratory use. The company's platform includes instruments, consumables, and informatics resources that support nucleic-acid extraction, assay development, sequencing workflows, and diagnostic analysis, enabling laboratories in biomedical research, healthcare, forensics, and biotechnology to conduct standardized testing, manage complex sample types, and generate reproducible molecular data.

Contact Information

Website
www.gentra.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 13355 Tenth Avenue North
  • Suite 120
  • Minneapolis, MN 55441
  • United States
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare Services
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 13355 Tenth Avenue North
  • Suite 120
  • Minneapolis, MN 55441
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gentra Systems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 30-Jun-2006 $38M Completed Product Development
1. Later Stage VC Completed Product Development
To view Gentra Systems’s complete valuation and funding history, request access »

Gentra Systems Patents

Gentra Systems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2007050327-A2 Compact apparatus, compositions and methods for purifying nucleic acids Inactive 21-Oct-2005
WO-2007050327-A3 Compact apparatus, compositions and methods for purifying nucleic acids Inactive 21-Oct-2005
WO-2006052680-A1 Compositions and methods for purifying nucleic acids from stabilization reagents Inactive 05-Nov-2004
WO-2006028616-A1 Compositions and methods for using a solid support to purify dna Inactive 02-Aug-2004
JP-2007515959-A Formulations and methods for denaturing proteins Active 16-Dec-2003 C07H21/00
To view Gentra Systems’s complete patent history, request access »

Gentra Systems Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Affinity Capital Management Venture Capital Minority
Brightstone Venture Capital Venture Capital Minority
Isabella Capital Venture Capital Minority
LFE Capital PE/Buyout Minority
Sofia Fund Angel Group Minority
You’re viewing 5 of 8 investors. Get the full list »

Gentra Systems FAQs

  • When was Gentra Systems founded?

    Gentra Systems was founded in 1988.

  • Where is Gentra Systems headquartered?

    Gentra Systems is headquartered in Minneapolis, MN.

  • What industry is Gentra Systems in?

    Gentra Systems’s primary industry is Discovery Tools (Healthcare).

  • Is Gentra Systems a private or public company?

    Gentra Systems is a Private company.

  • What is the current valuation of Gentra Systems?

    The current valuation of Gentra Systems is .

  • What is Gentra Systems’s current revenue?

    The current revenue for Gentra Systems is .

  • Who are Gentra Systems’s investors?

    Affinity Capital Management, Brightstone Venture Capital, Isabella Capital, LFE Capital, and Sofia Fund are 5 of 8 investors who have invested in Gentra Systems.

  • When was Gentra Systems acquired?

    Gentra Systems was acquired on 30-Jun-2006.

  • Who acquired Gentra Systems?

    Gentra Systems was acquired by Qiagen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process